Changes in GABA and GABA B receptor expressions are involved in neuropathy in the rat cuneate nucleus following median nerve transection

Seu Hwa Chen, Yi Ju Tsai, Chi Te Lin, Hsin Ying Wang, Shin Fang Li, June Horng Lue

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

This study examined the relationship between changes in GABA transmission and behavioral abnormalities after median nerve transection. Following unilateral median nerve transection, the percentage of GABA-like immunoreactive neurons in the cuneate nucleus and that of GABA B receptor-like immunoreactive neurons in the dorsal root ganglion in the injured side decreased and reached a nadir at 4 weeks after median nerve transection. Four weeks after bilateral median nerve transection and intraperitoneal application with saline, baclofen (2 mg kg -1), or phaclofen (2 mg kg -1) before unilateral electrical stimulation of the injured median nerve, we investigated the level of neuropeptide Y release and c-Fos expression in the stimulated side of the cuneate nucleus. The neuropeptide Y release level and the number of c-Fos-like immunoreactive neurons in the baclofen group were significantly attenuated, whereas those in the phaclofen group had increased compared to the saline group. These findings indicate that median nerve transection reduces GABA transmission, promoting injury-induced neuropeptide Y release and consequently evoking c-Fos expression in cuneate nucleus neurons. Furthermore, this study used the CatWalk method to assess behavioral abnormalities in rats following median nerve transection. These abnormalities were reversed by baclofen treatment. Overall, the results suggest that baclofen treatment block neuropeptide Y release, subsequently lessening c-Fos expression in cuneate neurons and consequently attenuating neuropathic signal transmission to the thalamus.

Original languageEnglish
Pages (from-to)561-572
Number of pages12
JournalSynapse
Volume66
Issue number6
DOIs
Publication statusPublished - Jun 2012

Fingerprint

GABA-B Receptors
Median Nerve
gamma-Aminobutyric Acid
Baclofen
Neuropeptide Y
Neurons
Spinal Ganglia
Thalamus
Electric Stimulation
Wounds and Injuries

Keywords

  • Baclofen
  • C-Fos
  • CatWalk
  • Neuropeptide Y
  • Phaclofen

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Changes in GABA and GABA B receptor expressions are involved in neuropathy in the rat cuneate nucleus following median nerve transection. / Chen, Seu Hwa; Tsai, Yi Ju; Lin, Chi Te; Wang, Hsin Ying; Li, Shin Fang; Lue, June Horng.

In: Synapse, Vol. 66, No. 6, 06.2012, p. 561-572.

Research output: Contribution to journalArticle

Chen, Seu Hwa ; Tsai, Yi Ju ; Lin, Chi Te ; Wang, Hsin Ying ; Li, Shin Fang ; Lue, June Horng. / Changes in GABA and GABA B receptor expressions are involved in neuropathy in the rat cuneate nucleus following median nerve transection. In: Synapse. 2012 ; Vol. 66, No. 6. pp. 561-572.
@article{e03ec55875e54c81804dd826af091f57,
title = "Changes in GABA and GABA B receptor expressions are involved in neuropathy in the rat cuneate nucleus following median nerve transection",
abstract = "This study examined the relationship between changes in GABA transmission and behavioral abnormalities after median nerve transection. Following unilateral median nerve transection, the percentage of GABA-like immunoreactive neurons in the cuneate nucleus and that of GABA B receptor-like immunoreactive neurons in the dorsal root ganglion in the injured side decreased and reached a nadir at 4 weeks after median nerve transection. Four weeks after bilateral median nerve transection and intraperitoneal application with saline, baclofen (2 mg kg -1), or phaclofen (2 mg kg -1) before unilateral electrical stimulation of the injured median nerve, we investigated the level of neuropeptide Y release and c-Fos expression in the stimulated side of the cuneate nucleus. The neuropeptide Y release level and the number of c-Fos-like immunoreactive neurons in the baclofen group were significantly attenuated, whereas those in the phaclofen group had increased compared to the saline group. These findings indicate that median nerve transection reduces GABA transmission, promoting injury-induced neuropeptide Y release and consequently evoking c-Fos expression in cuneate nucleus neurons. Furthermore, this study used the CatWalk method to assess behavioral abnormalities in rats following median nerve transection. These abnormalities were reversed by baclofen treatment. Overall, the results suggest that baclofen treatment block neuropeptide Y release, subsequently lessening c-Fos expression in cuneate neurons and consequently attenuating neuropathic signal transmission to the thalamus.",
keywords = "Baclofen, C-Fos, CatWalk, Neuropeptide Y, Phaclofen",
author = "Chen, {Seu Hwa} and Tsai, {Yi Ju} and Lin, {Chi Te} and Wang, {Hsin Ying} and Li, {Shin Fang} and Lue, {June Horng}",
year = "2012",
month = "6",
doi = "10.1002/syn.21539",
language = "English",
volume = "66",
pages = "561--572",
journal = "Synapse",
issn = "0887-4476",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Changes in GABA and GABA B receptor expressions are involved in neuropathy in the rat cuneate nucleus following median nerve transection

AU - Chen, Seu Hwa

AU - Tsai, Yi Ju

AU - Lin, Chi Te

AU - Wang, Hsin Ying

AU - Li, Shin Fang

AU - Lue, June Horng

PY - 2012/6

Y1 - 2012/6

N2 - This study examined the relationship between changes in GABA transmission and behavioral abnormalities after median nerve transection. Following unilateral median nerve transection, the percentage of GABA-like immunoreactive neurons in the cuneate nucleus and that of GABA B receptor-like immunoreactive neurons in the dorsal root ganglion in the injured side decreased and reached a nadir at 4 weeks after median nerve transection. Four weeks after bilateral median nerve transection and intraperitoneal application with saline, baclofen (2 mg kg -1), or phaclofen (2 mg kg -1) before unilateral electrical stimulation of the injured median nerve, we investigated the level of neuropeptide Y release and c-Fos expression in the stimulated side of the cuneate nucleus. The neuropeptide Y release level and the number of c-Fos-like immunoreactive neurons in the baclofen group were significantly attenuated, whereas those in the phaclofen group had increased compared to the saline group. These findings indicate that median nerve transection reduces GABA transmission, promoting injury-induced neuropeptide Y release and consequently evoking c-Fos expression in cuneate nucleus neurons. Furthermore, this study used the CatWalk method to assess behavioral abnormalities in rats following median nerve transection. These abnormalities were reversed by baclofen treatment. Overall, the results suggest that baclofen treatment block neuropeptide Y release, subsequently lessening c-Fos expression in cuneate neurons and consequently attenuating neuropathic signal transmission to the thalamus.

AB - This study examined the relationship between changes in GABA transmission and behavioral abnormalities after median nerve transection. Following unilateral median nerve transection, the percentage of GABA-like immunoreactive neurons in the cuneate nucleus and that of GABA B receptor-like immunoreactive neurons in the dorsal root ganglion in the injured side decreased and reached a nadir at 4 weeks after median nerve transection. Four weeks after bilateral median nerve transection and intraperitoneal application with saline, baclofen (2 mg kg -1), or phaclofen (2 mg kg -1) before unilateral electrical stimulation of the injured median nerve, we investigated the level of neuropeptide Y release and c-Fos expression in the stimulated side of the cuneate nucleus. The neuropeptide Y release level and the number of c-Fos-like immunoreactive neurons in the baclofen group were significantly attenuated, whereas those in the phaclofen group had increased compared to the saline group. These findings indicate that median nerve transection reduces GABA transmission, promoting injury-induced neuropeptide Y release and consequently evoking c-Fos expression in cuneate nucleus neurons. Furthermore, this study used the CatWalk method to assess behavioral abnormalities in rats following median nerve transection. These abnormalities were reversed by baclofen treatment. Overall, the results suggest that baclofen treatment block neuropeptide Y release, subsequently lessening c-Fos expression in cuneate neurons and consequently attenuating neuropathic signal transmission to the thalamus.

KW - Baclofen

KW - C-Fos

KW - CatWalk

KW - Neuropeptide Y

KW - Phaclofen

UR - http://www.scopus.com/inward/record.url?scp=84862791259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862791259&partnerID=8YFLogxK

U2 - 10.1002/syn.21539

DO - 10.1002/syn.21539

M3 - Article

C2 - 22290688

AN - SCOPUS:84862791259

VL - 66

SP - 561

EP - 572

JO - Synapse

JF - Synapse

SN - 0887-4476

IS - 6

ER -